Pallas Capital Advisors LLC

Source: SEC Form 13F · as of Mar 2026

Pallas Capital Advisors LLC holds 58 biotech & pharma companies tracked by BioSniper, totaling $107.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

58

Total value held

$107.0M

CompanySharesValue
JNJJOHNSON & JOHNSON75,774$18.5M
LLYELI LILLY & Co9,796$9.0M
ABTABBOTT LABORATORIES86,541$8.9M
MRKMerck & Co., Inc.67,542$8.1M
AXSMAxsome Therapeutics, Inc.40,610$6.9M
BMYBRISTOL MYERS SQUIBB CO92,264$5.6M
ABBVAbbVie Inc.25,441$5.5M
RPRXRoyalty Pharma plc102,969$4.9M
GMOptec International, Inc.63,208$4.7M
INCYIncyte Corp.33,157$3.1M
MCKMcKesson Corporation2,918$2.5M
BIIBBIOGEN INC.11,963$2.2M
PMPhilip Morris International Inc12,696$2.1M
REGNREGENERON PHARMACEUTICALS, INC.2,680$2.1M
IQVIQVIA Holdings Inc.10,412$1.8M
UNHUnitedHealth Group Incorporated Common Stock (DE)6,347$1.7M
PFEPFIZER INC57,119$1.6M
NBIXNEUROCRINE BIOSCIENCES INC12,133$1.6M
WSTWest Pharmaceutical Services Inc.6,359$1.6M
MEDPMedpace Holdings Inc.3,290$1.6M
AMGNAMGEN INC4,262$1.5M
UTHRUNITED THERAPEUTICS Corp2,311$1.4M
GILDGILEAD SCIENCES, INC.7,558$1.1M
IDXXIDEXX LABORATORIES INC /DE1,806$1.0M
MOHMolina Healthcare Inc6,274$836K
ALNYALNYLAM PHARMACEUTICALS, INC.2,212$732K
VRTXVERTEX PHARMACEUTICALS INC / MA1,638$731K
BMRNBIOMARIN PHARMACEUTICAL INC12,396$700K
KNSAKiniksa Pharmaceuticals International, plc7,716$372K
ELVElevance Health Inc.1,078$316K
ARWRARROWHEAD PHARMACEUTICALS, INC.4,728$296K
RLAYRelay Therapeutics, Inc.28,573$284K
IRWDIRONWOOD PHARMACEUTICALS INC80,567$283K
ACADACADIA PHARMACEUTICALS INC12,291$274K
ZTSZoetis Inc.2,256$267K
SRPTSarepta Therapeutics, Inc.12,152$264K
JAZZJazz Pharmaceuticals plc1,320$250K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)4,471$247K
SNDXSyndax Pharmaceuticals Inc9,716$227K
NVSNovartis AG1,484$227K
PTCTPTC THERAPEUTICS, INC.3,090$211K
ERASErasca, Inc.12,148$197K
NUVBNuvation Bio Inc.44,082$189K
KURAKura Oncology, Inc.21,414$174K
ARDXARDELYX, INC.25,744$154K
BHVNBiohaven Ltd.16,708$141K
SANASana Biotechnology, Inc.39,245$113K
RGNXREGENXBIO Inc.13,119$110K
RCKTRocket Pharmaceuticals Inc.19,635$70K
XERSXeris Biopharma Holdings, Inc.11,121$65K
ALLOAllogene Therapeutics, Inc.26,238$64K
LRMRLarimar Therapeutics, Inc.11,162$50K
ORGOOrganogenesis Holdings Inc.18,685$44K
EDITEditas Medicine, Inc.16,576$41K
FATEFATE THERAPEUTICS INC22,430$27K
CHRSCoherus Oncology, Inc.11,545$20K
HUMAHumacyte Inc.21,600$13K
GOSSGossamer Bio, Inc.10,367$3K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Pallas Capital Advisors LLC — Biotech 13F Holdings & Portfolio | BioSniper